Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
AYTU
#3660
AYTU BioPharma, Inc. Common Stock
2.5
7
+3.21%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+3.21%
Aylık değişim
-3.02%
6 aylık değişim
+7.98%
Yıllık değişim
+102.36%
Önceki kapanış
2.4
9
Open
2.5
7
Bid
Ask
Low
2.5
7
High
2.5
7
Hacim
1
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
AYTU
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.38 M
3.12 M
5.53 M
6.15 M
9.91 M
—
Valuation ratios
Enterprise value
—
—
2.43 M
10.79 M
-9.34 M
-35.71 M
Price to earnings ratio
—
—
-0.31
1
1.01
15.4
Price to sales ratio
—
—
0.05
0.19
0.21
0.95
Price to cash flow ratio
—
—
1.05
11.37
7.07
140.17
Price to book ratio
—
—
0.14
0.57
0.72
1.21
Enterprise value to EBITDA ratio
—
—
-0.29
3.58
3.69
28.5
Profitability ratios
Return on assets %
0.22
0.8
0.13
0.13
0.11
0.19
Return on equity %
0.42
2.39
0.43
0.57
0.72
1.33
Return on invested capital %
164.04
299.93
74.28
27.24
55.94
58.22
Gross margin %
44.49
54.08
62.04
67.39
69.04
266.76
Operating margin %
89.7
115.41
15.89
6.49
11.79
55.32
EBITDA margin %
-75.68
-104.8
-7.68
3.73
-3.81
-18.6
Net margin %
88.81
113.97
15.92
19.56
20.43
153.86
Liquidity ratios
Quick ratio
0.81
0.76
0.88
1.79
1.07
4.05
Current ratio
0.96
0.93
1.06
1.99
1.26
4.67
Inventory turnover
0.55
0.16
3.57
2.15
1.71
1.97
Asset turnover
0.31
0.48
0.78
0.64
0.55
0.51
Solvency ratios
Debt to assets ratio
—
—
0.12
0.11
—
—
Debt to equity ratio
—
—
0.42
0.48
—
—
Long term debt to total assets ratio
0.06
0.11
0.11
0.09
0.09
0.33
Long term debt to total equity ratio
0.12
0.33
0.38
0.39
0.57
2
Per share metrics
Operating cash flow per share
—
19.59
1.53
0.25
0.31
0.2
EBIT per share
—
-75.9
-5.11
-0.95
-1.25
-1.19
EBITDA per share
—
-68.92
-2.47
0.54
-0.4
-0.35
Total debt per share
—
—
4.96
2.4
—
—
Cash per share
—
13.17
6.88
3.61
4.93
11.81
Net current asset value per share
—
40.77
21.81
22.35
12.61
33.21
Tangible book value per share
—
-16.7
-5.87
-4.47
-3.7
-9.25
Working capital per share
—
-3.07
1.14
11.11
2.57
4.63
Book value per share
—
31.36
11.78
5
3.02
9.88
Haberler
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
Aytu BioPharma’nın 2026 2. Çeyrek Kazanç Raporu: Gelir Düşüşü, Hisse Değer Kaybetti
Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls
New Strong Sell Stocks for February 2nd
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20
Aytu, depresyon için ilk seçici 5-HT1A agonisti EXXUA’yı piyasaya sürüyor
Aytu launches EXXUA, first selective 5-HT1A agonist for depression
Aytu BioPharma hisseleri depresyon ilacı EXXUA’nın ticari lansmanı sonrası yükseldi
Aytu BioPharma stock rises after commercial launch of depression drug EXXUA
Aytu BioPharma launches depression drug EXXUA in U.S. market